Director Drug Substance Network strategy

Johnson & Johnson Innovative Medicine•Hopewell Township, NJ

22h•Onsite

About The Position

The Director, Drug Substance (DS) network strategy is responsible for developing and maintaining portfolio and network level strategies, associated investment approvals, and ensuring timely decisions on portfolio and network needs for the biotherapeutic platform. This role supports product and portfolio network sourcing council reviews for products, portfolios, and network strategies, and assists VCLS in product strategy roadmap definition. Key outcomes for this role are delivering a prescriptive unified network, cross-product strategies for portfolios, prioritization within network and portfolio, investment roadmap, and data-based portfolio and network decisions made on time.

Requirements

A minimum of a bachelor’s degree in Science, Engineering, Business, or related field.
A minimum of ten (10) years combined experience relevant to supply chain.
Experience leading large, complex, and interdependent initiatives in a matrix environment.
Strong analytical, problem-solving, and critical thinking skills.
Demonstrated ability to translate trends and insights into actional strategies that can be deployed in real-world applications
Ability to communicate clearly and concisely across all levels of the company and across our global supply chain.
Strong business acumen with solid understanding of end-to-end supply chain processes.
Proven experience in managing against a budget and making decisions that draw upon effective business and financial acumen, including making financial assessments of strategic options and providing recommendations.
Skills demonstrated in influencing across the matrix and negotiating in situations without positional authority.
Experience working within different cultures, as well as handling diverse and complex cultural and market-specific issues, such as labor laws, healthcare regulatory requirements, tax law and logistics
Detail and solution oriented with ability to work within broad guidelines and exercise considerable initiative, judgment, and decisiveness
Commitment to advancing our Diversity, Equity, and Inclusion goals, including in how we attract, develop, and retain talent.
Verbal and written proficiency in English

Nice To Haves

Master’s degree in Science, Engineering, Business, or related field or an MBA.
Biotherapeutic drug substance experience.
Experience working across multiple business segments, functions and/or regions.
Prior experience in pharmaceutical manufacturing and/or logistics operations.

Responsibilities

Responsible for biotherapeutic Drug Substance (DS) product portfolio and network strategy
Develop and maintain portfolio & network level strategy & associated investment approvals and ensuring timely decisions on portfolio and network level strategies for DS
Lead the development and deployment of network strategies across the end-to-end biotherapeutic DS supply chain to meet the needs of the current product portfolio as well as the emerging pipeline. This will include investments in new capacities and capabilities, rationalization of legacy assets and identification of leveraging/partnering opportunities to ensure an agile, resilient, and cost-effective network.
Create coherent strategy and prioritization across products with similar profiles (technology, process, and capabilities, etc.)
Create and communicate meaningful network guidance across the biotherapeutic drug substance platform in partnership with cross functional heads. This includes gaining leadership alignment and endorsement of core/non-core capabilities, network roadmaps, product portfolio and site missions.
Maintain strong connections to the upstream R&D (Discovery, Product Development and Supply) as well as the downstream Commercial organization to ensure solutions incorporate broad and diverse insights while ensuring end-to-end optimization.
Partner with Value Chain Management to generate siting options for new and existing products aligned to overarching network strategy.
Build and maintain external connections relevant to identifying marketplace and industry trends.
Drive analysis and decisions required from a planned or unplanned ‘trigger event’ (e.g., uptick in demand, capacity gap, etc.)
Trigger portfolio and network assessments where capacity and capability gaps exist